On-treatment and Sustained Virologic Response Rates of Telaprevir-based HCV Treatments Do Not Differ Between HIV/HCV Co-infected and HCV Mono-infected Patients
Reported by Jules Levin
CROI 2013 poster/Updated at ICVH March 25-26 oral
Martel-Laferriere V, Brinkley S, Bichoupan K, Posner S, Stivala A, Perumalswami P, Schiano T,
Sulkowski M, Dieterich DT, Branch AD
